Finance

Lists
Why is TXG down 10,07%?
Dive Deeper
TXG:NASDAQ
10X Genomics Inc
87,90 $
-10,07%
(-9,85) 1D
6 қаз., 10:38:57 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TXG...
Open
100,33 $
High
102,81 $
Low
87,25 $
Mkt. cap
10,96 млрд
Avg. vol.
2,99 млн
Volume
2,15 млн
52-wk high
102,81 $
52-wk low
11,16 $
EPS
-0,59 $
Beta
1,99
Shares outstanding
120,21 млн
No. of employees
1 мың
Open
100,33 $
High
102,81 $
Low
87,25 $
Mkt. cap
10,96 млрд
Avg. vol.
2,99 млн
Volume
2,15 млн
52-wk high
102,81 $
52-wk low
11,16 $
EPS
-0,59 $
Beta
1,99
Shares outstanding
120,21 млн
No. of employees
1 мың
News stories
From web sources and news partners
Profile
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics. Wikipedia
About 10X Genomics Inc
CEOSerge Saxonov
Employees1,18 мың
Founded2012
HeadquartersPleasanton, Калифорния, Америка Құрама Штаттары
Sector-
Analyst ratings
Based on 16 analysts giving stock ratings to TXG in the past 3 months
Buy
Buy
7
Hold
9
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for TXG in the last 3 months.
Highest
Current 87,90 $
110,00 $ (+25,15%)
Average
63,21 $ (-28,08%)
Lowest
40,00 $ (-54,49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matt Larew
William Blair
Buy
Maintained
-
-
09/29/2026
Puneet Souda
Leerink Partners
Hold
Maintained
90,00 $
+2,4%
09/29/2026
David Westenberg
Piper Sandler
Hold
Reiterated
80,00 $
-9%
09/28/2026
Unknown Analyst
Argus Research
Buy
Initiated
110,00 $
+25,1%
09/28/2026
John Eade
Argus Research
Buy
Initiated
110,00 $
+25,1%
09/25/2026
Unknown Analyst
UBS
Hold
Initiated
68,00 $
-22,6%
09/08/2026
Doug Schenkel
UBS
Hold
Maintained
68,00 $
-22,6%
09/09/2026
Dan Leonard
RBC Capital
Hold
Initiated
70,00 $
-20,4%
09/01/2026
Unknown Analyst
Stephens
Buy
Reiterated
65,00 $
-26%
08/12/2026
Casey Woodring
J.P. Morgan
Hold
Maintained
50,00 $
-43,1%
08/10/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
50,00 $
-43,1%
08/11/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
60,00 $
-31,7%
08/10/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Reiterated
40,00 $
-54,5%
08/10/2026
Michael Ryskin
Bank of America Securities
Hold
Maintained
-
-
08/07/2026
Tycho Peterson
Jefferies
Buy
Reiterated
53,00 $
-39,7%
08/07/2026
Patrick B Donnelly
Citi
Hold
Maintained
50,00 $
-43,1%
08/07/2026
‏Brendan Digan‏
Citi
Hold
Maintained
50,00 $
-43,1%
08/07/2026
Luke Sergott
Barclays
Buy
Maintained
52,00 $
-40,8%
08/06/2026
Daniel Brennan
TD Cowen
Hold
Maintained
47,00 $
-46,5%
07/15/2026
Justin Bowers
Deutsche Bank
Hold
Maintained
23,00 $
-73,8%
05/08/2026
Last report
2026 ж. 06 там.
Fiscal period
Q2 2026
EPS / Est. (USD)
0,03 $ / -0,02 $
+258,37%beat
Revenue / Est. (USD)
151,04 млн / 146,62 млн
+3,01%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
149,00 млн
166,03 млн
150,84 млн
151,04 млн
Cost of goods sold
48,70 млн
52,88 млн
44,66 млн
38,54 млн
Cost of revenue
48,70 млн
52,88 млн
44,66 млн
38,54 млн
Research and development expenses
57,19 млн
55,77 млн
56,85 млн
56,79 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
74,66 млн
73,02 млн
66,38 млн
78,66 млн
Operating expense
131,85 млн
128,79 млн
123,22 млн
135,45 млн
Total operating expenses
180,54 млн
181,67 млн
167,89 млн
173,99 млн
Operating income
-31,54 млн
-15,64 млн
-17,05 млн
-22,96 млн
Other non operating income
538,00 м.
-3,04 млн
-72,00 мың
-3,49 млн
EBT including unusual items
-28,20 млн
-15,19 млн
-12,85 млн
-18,64 млн
EBT excluding unusual items
-26,40 млн
-12,39 млн
-12,90 млн
-22,04 млн
Income tax expense
-733,00 м.
1,06 млн
623,00 м.
-714,00 м.
Effective tax rate
2,60%
-6,97%
-4,85%
3,83%
Other operating expenses
-
-
-
-
Net income
-27,47 млн
-16,25 млн
-13,47 млн
-17,93 млн
Net profit margin
-18,44%
-9,79%
-8,93%
-11,87%
Earnings per share
-0,02
0,07
0,07
0,03
Interest and investment income
5,20 млн
6,89 млн
5,01 млн
4,80 млн
Interest expense
-
-
-
-
Net interest expenses
5,20 млн
6,89 млн
5,01 млн
4,80 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,24 млн
-5,58 млн
-7,09 млн
-13,29 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары